Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy-, 6-ether with N-[6-[[[1-[[2-[3,6-bis(2,3-dihydro-1H-indol-1-yl)xanthylium-9-yl]phenyl]sulfonyl]-4-piperidinyl]carbonyl]amino]-1-oxohexyl]glycylglycyl-L-arginyl-N6-[6-[2-[5-(1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene)-1,3-pentadien-1-yl]-3,3-dimethyl-5-sulfo-3H-indolio]-1-oxohexyl]-L-lysyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-S-[1-[6-[(2-hydroxyethyl)amino]-6-oxohexyl]-2,5-dioxo-3-pyrrolidinyl]-L-cysteinamide bis(inner salt), acetate (1:1) Structure

Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy-, 6-ether with N-[6-[[[1-[[2-[3,6-bis(2,3-dihydro-1H-indol-1-yl)xanthylium-9-yl]phenyl]sulfonyl]-4-piperidinyl]carbonyl]amino]-1-oxohexyl]glycylglycyl-L-arginyl-N6-[6-[2-[5-(1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene)-1,3-pentadien-1-yl]-3,3-dimethyl-5-sulfo-3H-indolio]-1-oxohexyl]-L-lysyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-S-[1-[6-[(2-hydroxyethyl)amino]-6-oxohexyl]-2,5-dioxo-3-pyrrolidinyl]-L-cysteinamide bis(inner salt), acetate (1:1)

Chemical Properties

FDA UNII F3F6208UMT

Preparation Products And Raw materials

Poly(oxy-1,2-ethanediyl), α-methyl-ω-hydroxy-, 6-ether with N-[6-[[[1-[[2-[3,6-bis(2,3-dihydro-1H-indol-1-yl)xanthylium-9-yl]phenyl]sulfonyl]-4-piperidinyl]carbonyl]amino]-1-oxohexyl]glycylglycyl-L-arginyl-N6-[6-[2-[5-(1-ethyl-1,3-dihydro-3,3-dimethyl-5-sulfo-2H-indol-2-ylidene)-1,3-pentadien-1-yl]-3,3-dimethyl-5-sulfo-3H-indolio]-1-oxohexyl]-L-lysyl-2-[2-(2-aminoethoxy)ethoxy]acetyl-S-[1-[6-[(2-hydroxyethyl)amino]-6-oxohexyl]-2,5-dioxo-3-pyrrolidinyl]-L-cysteinamide bis(inner salt), acetate (1:1) Suppliers